Brief: FDA Authorizes First Single-Use, PCR Quality Over The Counter Lucira Check It Covid-19 At-Home Test
April 12 (Reuters) - Lucira Health Inc LHDX.O :
* FDA AUTHORIZES FIRST SINGLE-USE, PCR QUALITY OVER THE
COUNTER
(OTC) LUCIRA CHECK IT™ COVID-19 AT-HOME TEST. AVAILABLE NOW.
* LUCIRA HEALTH INC - LUCIRA CHECK IT TEST KIT CAN BE
ORDERED FOR
$55
* LUCIRA HEALTH INC - EXPECTS NET REVENUE FOR Q1 OF
APPROXIMATELY
$4.0 MILLION TO $4.5 MILLION
* LUCIRA HEALTH INC - LUCIRA CHECK IT TEST KIT DELIVERS PCR
QUALITY MOLECULAR ACCURACY IN 30 MINUTES OR LESS AT HOME
Source text for Eikon: ID:nBw1wCVdBa
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process